Use of Fenofibrate in Asparaginase-Induced Hypertriglyceridemia in Children with ALL: a Case Series

Roxane Therrien, Pierre Barret, Marthe Robitaille & Albert Mohghrabi
Leukemia patients receiving asparaginase sometime develop hypertriglyceridemia requiring delays in therapy despite severe hypolipidic diet. This paper reports on the use of fenofibrate in ten pediatric patients with ALL. Fenofibrate was tried in order to improve quality of life, avoid delays in therapy and pursue optimal treatment of ALL despite the lack of information on this treatment. Before adding the fenofibrate, the average triglyceridemia for these patients was a median 4.60 mmol/L, and it was...
This data repository is not currently reporting usage information. For information on how your repository can submit usage information, please see our documentation.